MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: A randomised controlled trial

The George Institute for Global Health0 个研究点目标入组 156 人开始时间: 2016年5月20日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Participants will be eligible if they have a confirmed diagnosis of coronary heart disease, including a prior diagnosis of myocardial infarction, stable or unstable angina, coronary revascularisation procedure or current admission with an acute coronary syndrome event or >50% stenosis in at least one major vessel on the coronary angiogram. In addition, participants will have to meet the following criteria: 1) be an adult (> 18 years), 2) own an active smartphone that operates with iOS or Android operating systems, 3) have sufficient English skills, and 4) provide written informed consent.

•Patients will be excluded if they already use a medication reminder app or other electronic reminder systems to help them adhere to their medication regimen, e.g. calendar alerts in their phones. In addition, smartphones that are not capable of downloading the apps, for example older Apple iPhones, such as iPhones 4, that operate with older iOS versions, will be excluded, as the basic app is only compatible with iOS version 7.0 or later and the advanced app with iOS version 8.0 or later.

发起方